A Quote by Jaime Harrison

Medicare should be allowed to negotiate with drug companies for lower prices on prescriptions. — © Jaime Harrison
Medicare should be allowed to negotiate with drug companies for lower prices on prescriptions.
I'd never have guessed that, six years after Medicare introduced a drug benefit, it would still be forbidden to negotiate prices with pharmaceutical companies. Health reform might fix that, but it probably won't.
Democrats believe we must have comprehensive health care reform that includes giving the federal government authority to negotiate lower prices with drug companies.
When I was in the Maine Senate and proposed Maine RX - a plan to lower prescription drug costs by forcing the pharmaceutical companies to negotiate - I was told by many people that it was too big an idea, and we couldn't overcome opposition from the drug companies.
The same drugs are way cheaper in Germany than in America because, obviously, if all sickness funds negotiate with the drug companies for a single price, then the market power of the sickness funds is fully used. So therefore you would expect the prices to be lower for the drugs in Germany, and this is exactly what you see, at least for non-generic drugs.
In case you haven't noticed, a large wall is being built around the American people to ensure that they remain prisoner to the drug industry. It's easy to understand why drug makers want to force Americans to buy their products in the United States. Ours is the only industrialized country that doesn't negotiate the prices the drug companies may charge. As a result, a 90-day supply of Fosamax sells for $105 in Canada but $210 here.
I support negotiating authority to lower prescription drug prices.
In every country except - industrial country except the United States, the government uses its massive purchasing power to negotiate drug prices. That's one of the reasons prices are so much higher in the United States than in other countries.
20 million people thrown off of health insurance, prescription drug prices raising for seniors, privatization of Medicare: devastation. And we've got to fight back against that.
The intelligent investor should recognize that market panics can create great prices for good companies and good prices for great companies.
Drug companies should not be allowed to reap excessive profits or spend unreasonable amounts on marketing if they want to receive support that is designed to encourage life- saving and health-improving treatments.
We must advocate for policies that stabilize our health care markets, lower premiums and drug costs, protect Medicare and address Nevada's physician residency shortage.
To economists, prices serve as crucial signals to producers and consumers. In a regulated market, the state sets prices high enough for private companies to cover their costs and earn a guaranteed profit for their investors. But in a deregulated market, prices should vary with demand and supply.
The Medicare Part D prescription drug bill, which might be the most corrupt piece of legislation in history, was a huge giveaway of taxpayer funds to the big pharmaceutical companies.
Trump promised to bring back jobs. He promised to lower drug prices for so many Kentuckians. And that is very important.
Consolidation in the skiing equipment industry cannot be allowed to lead to higher prices, lower quality or less innovative products.
If we are enforcing what should be the rules around Medicare and making sure the people are getting the bang for the buck, it's not going to be possible for insurance companies to simply pass on those costs to Medicare recipients, because ultimately it's Uncle Sam that's paying for those services anyway.
This site uses cookies to ensure you get the best experience. More info...
Got it!